MET Biotechnology Inc. — Form D
MET Biotechnology Inc. of CULVER CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-09. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Other.
Offering
- Filed: 2024-02-09
- Form: D
- Accession: 0002011292-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Investors: 4
- Date of first sale: 2024-01-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-504896
Issuer
- Name: MET Biotechnology Inc.
- CIK: 0002011292
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 10827 WHITBURN STREET, CULVER CITY, CA, 90230
- Phone: 310-310-1226
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Pei-Yu Chiou | Director | Culver City, CA |
| Michael A Teitell | Director | Culver City, CA |
| Ting-Hsiang Wu | Director | Culver City, CA |
| Tung-Yu Wu | Director | MENLO PARK, CA |
| Ting-Hsiang Wu | Executive Officer | Culver City, CA |
More